StocksMedium•13 November 2026•
1 min read
ProKidney Reports Wider-Than-Expected Q3 Loss
Key Facts
1ProKidney Corp. reported a quarterly loss of $0.17 per share, wider than the Zacks Consensus Estimate of a $0.13 loss.
2The company's loss widened compared to the same quarter last year, which saw a loss of $0.12 per share.
ProKidney Corp. reported a quarterly loss of $0.17 per share for the third quarter of 2026. According to Zacks, this figure was wider than the $0.13 loss per share anticipated by analyst estimates, marking a miss on the company's bottom-line performance.
The company's losses widened from the same period last year, when it reported a loss of $0.12 per share. Shares of PROK closed at $1.13 on November 11, 2026, having traded between a session high of $1.18 and a low of $1.11.